The role of gastric function in control of food intake (and body weight) in relation to obesity, as well as pharmacological and surgical interventions

被引:7
作者
Camilleri, Michael [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Clin Enter Neurosci Translat & Epidemiol Res CENTE, Charlton Bldg,Rm 8-110,200 First St SW, Rochester, MN 55905 USA
关键词
food intake; stomach; weight loss; GLUCAGON-LIKE PEPTIDE-1; POSTPRANDIAL SYMPTOMS; ENERGY-INTAKE; PERFORMANCE-CHARACTERISTICS; SCINTIGRAPHIC MEASUREMENT; EMPTYING SCINTIGRAPHY; JEJUNAL MOTILITY; ANTRAL AREA; ILEAL BRAKE; SOLID FOOD;
D O I
10.1111/nmo.14660
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PurposeThe objectives of this review are to summarize the role of gastric motor functions in the development of satiation (defined broadly as postprandial fullness) and satiety (reduced appetite or postponing desire to eat after a meal) and their impact on weight change. The specific topics are the methods of measurement of gastric emptying and accommodation and their impact on food intake, satiation, and satiety. A second focus contrasts bariatric surgery to endoscopic gastroplasty that alter gastric emptying and incretin responses in markedly divergent manners.BackgroundThe hormone, GLP-1, retards gastric emptying and increases gastric accommodation through vagally-mediated effects. Indeed, these effects provide the basis for the association of altered gastric emptying in the appetite and weight loss responses to pharmacological interventions particularly by those acting on receptors of incretin agonists such as liraglutide and the dual agonists, tirzepatide and cotadutide, all of which retard gastric emptying. In fact, retardation of gastric emptying and gastrointestinal adverse effects have been shown to contribute in part to the weight loss in response to this class of pharmacological agents.SummaryThe motor functions of the stomach are relevant to postprandial fullness and to interventions aimed at weight loss in people with obesity.
引用
收藏
页数:8
相关论文
共 81 条
[1]   Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine [J].
Abell, Thomas L. ;
Camilleri, Michael ;
Donohoe, Kevin ;
Hasler, William L. ;
Lin, Henry C. ;
Maurer, Alan H. ;
McCallum, Richard W. ;
Nowak, Thomas ;
Nusynowitz, Martin L. ;
Parkman, Henry P. ;
Shreve, Paul ;
Szarka, Lawrence A. ;
Snape, William J., Jr. ;
Ziessman, Harvey A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (03) :753-763
[2]   Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals [J].
Abu Dayyeh, Barham K. ;
Acosta, Andres ;
Camilleri, Michael ;
Mundi, Manpreet S. ;
Rajan, Elizabeth ;
Topazian, Mark D. ;
Gostout, Christopher J. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (01) :37-+
[3]   Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic [J].
Acosta, Andres ;
Camilleri, Michael ;
Abu Dayyeh, Barham ;
Calderon, Gerardo ;
Gonzalez, Daniel ;
McRae, Alison ;
Rossini, William ;
Singh, Sneha ;
Burton, Duane ;
Clark, Matthew M. .
OBESITY, 2021, 29 (04) :662-671
[4]   Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study [J].
Acosta, Andres ;
Camilleri, Michael ;
Burton, Duane ;
O'Neill, Jessica ;
Eckert, Deborah ;
Carlson, Paula ;
Zinsmeister, Alan R. .
PHYSIOLOGICAL REPORTS, 2015, 3 (11)
[5]   Quantitative Gastrointestinal and Psychological Traits Associated With Obesity and Response to Weight-Loss Therapy [J].
Acosta, Andres ;
Camilleri, Michael ;
Shin, Andrea ;
Vazquez-Roque, Maria I. ;
Iturrino, Johanna ;
Burton, Duane ;
O'Neill, Jessica ;
Eckert, Deborah ;
Zinsmeister, Alan R. .
GASTROENTEROLOGY, 2015, 148 (03) :537-+
[6]   Recent advances in clinical practice challenges and opportunities in the management of obesity [J].
Acosta, Andres ;
Abu Dayyeh, Barham K ;
Port, John D ;
Camilleri, Michael .
GUT, 2014, 63 (04) :687-+
[7]   Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial [J].
Ahmann, Andrew J. ;
Capehorn, Matthew ;
Charpentier, Guillaume ;
Dotta, Francesco ;
Henkel, Elena ;
Lingvay, Ildiko ;
Holst, Anders G. ;
Annett, Miriam P. ;
Aroda, Vanita R. .
DIABETES CARE, 2018, 41 (02) :258-266
[8]   Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials [J].
Ahren, Bo ;
Atkin, Stephen L. ;
Charpentier, Guillaume ;
Warren, Mark L. ;
Wilding, John P. H. ;
Birch, Sune ;
Holst, Anders Gaarsdal ;
Leiter, Lawrence A. .
DIABETES OBESITY & METABOLISM, 2018, 20 (09) :2210-2219
[9]   Gastrointestinal hormones and appetite ratings after weight loss induced by diet or bariatric surgery [J].
Aukan, Marthe Isaksen ;
Skarvold, Silje ;
Brandsaeter, Ingrid Ofsti ;
Rehfeld, Jens Frederik ;
Holst, Jens Juul ;
Nymo, Siren ;
Coutinho, Silvia ;
Martins, Catia .
OBESITY, 2023, 31 (02) :399-411
[10]   SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication [J].
Bouras, EP ;
Delgado-Aros, S ;
Camilleri, M ;
Castillo, EJ ;
Burton, DD ;
Thomforde, GM ;
Chial, HJ .
GUT, 2002, 51 (06) :781-786